Analysis of Exposure to Foreign Exchange Risk for U.S. Pharmaceutical Industry

DOI

10.2991/isbcd-17.2017.45How to use a DOI?

Keywords

Pharmaceutical industry; foreign operations; exposure to foreign exchange risk; risk management

Abstract

Multinational companies with a large proportion of foreign operations face one same problem which is foreign exchange risk. As for the world's largest economy, the United States has various kinds of industries that have global business and trade with currencies of different countries. American pharmaceutical industry is a very typical one, and I choose five sample firms (Merck, AbbVie, Pfizer, Bristol Myers and GSK) with comparably large size, healthy financial status and a lot of international business to analyze the exposure to foreign exchange risk and discuss the management of the risk and finally come up with my own recommendations.

Copyright

© 2017, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Shuting Niu
PY  - 2017/10
DA  - 2017/10
TI  - Analysis of Exposure to Foreign Exchange Risk for U.S. Pharmaceutical Industry
BT  - Proceedings of the 2nd International Symposium on Business Corporation and Development in South-East and South Asia under B&R Initiative (ISBCD 2017)
PB  - Atlantis Press
SP  - 220
EP  - 225
SN  - 2352-5428
UR  - https://doi.org/10.2991/isbcd-17.2017.45
DO  - 10.2991/isbcd-17.2017.45
ID  - Niu2017/10
ER  -